Associate Director of the Christy Houston Drug Information Center
Assistant Professor of Pharmaceutical, Social and Administrative Science
Pharm.D. (Pharmacy), University of the Sciences in Philadelphia, Philadelphia, PA
Dr. Genevieve Ness graduated from the University of the Sciences in Philadelphia, Pennsylvania where she received her Pharm.D. degree in May 2011. During her pharmacy education she gained experience in retail pharmacy (CVS), hospital pharmacy (Wuesthoff Health System), the pharmaceutical industry (GlaxoSmithKline), and hospice pharmacy (Enclara Health). From these experiences, Dr. Ness determined that drug information was an area she wanted to pursue and she obtained a fellowship position upon graduation.
Dr. Ness began the Regulatory Pharmaceutical Fellowship with a focus in drug information cosponsored by Purdue University, Eli Lilly and Company, and the Food and Drug Administration (FDA) in the summer of 2011. She began the fellowship at Purdue University where she assisted with the “Principles of Drug Information and Literature Evaluation” course. In addition, Dr. Ness gained experience at Indiana University’s Center for Medication Management and Wishard Memorial Hospital (Eskenazi Health) where she had the opportunity to answer various drug information questions and prepare monographs to be presented at the hospital’s monthly P&T committee meeting. During her academia experience, Dr. Ness also completed the requirements for the Indiana Teaching Certificate program.
Dr. Ness began the industry portion of her fellowship with Eli Lilly & Company in January 2012 where she held responsibilities in both Global Information Disclosure and Global Medical Information. Within the Global Information Disclosure department, she provided weekly updates of innovative technologies and current events, researched and explored various ground-breaking social media tools, and assisted in the development and implementation of Lilly Wikipedia activities. Her responsibilities in Global Medical Information included creating and updating Cymbalta® (duloxetine) & Amyvid™ (florbetapir) medical letters and Cymbalta® custom written responses. In addition, Dr. Ness answered United States & global Cymbalta® escalations, as well as conducted peer and data integrity reviews for Cymbalta® (duloxetine) medical letters.
Dr. Ness completed her fellowship at the FDA‘s Division of Drug Information where she facilitated the development of the World Health Organization (WHO) Public Assessment Report (PAR) for all United States FDA tentatively approved and approved President’s Emergency Plan for AIDS Relief (PEPFAR) products. She responded to MedWatch and drug information related inquiries from consumers, healthcare professionals, and the pharmaceutical industry via telephone and email. In addition, Dr. Ness communicated to healthcare professionals and consumers through Drug Information Rounds video scripts, Twitter postings, Listserv emails, and Drug Safety Podcasts. Dr. Ness continues to maintain her connection with the FDA through her service on the Global Alliance of Drug Information Specialists (GADIS) committee. She has presented a global based webinar to the members of this committee and participates in the creation of the monthly News and Notes update.
Dr. Ness joined the faculty at the Belmont University College of Pharmacy in August of 2013. She teaches in the “Introduction to Drug Information and Informatics” course as well as the “Biomedical Literature for Pharmacy” course. Dr. Ness serves as a peer reviewer for the Annals of Pharmacotherapy, an abstract reviewer for the American Pharmacists Association Contributed Papers Program, and has been published in the Drug Information Association Global Forum, the American Journal of Pharmaceutical Education, and the Journal of the American Pharmacists Association.